Pistole Labs’ Post

A niche service before the pandemic, telemedicine experienced a dramatic demand surge in 2020, followed by settling to a new, much higher, baseline as life returned to normal. Since the peak of telemedicine venture funding in 2022, there has been a consistent stream of negative stories about telemedicine companies, shutdowns like Optum Virtual Care and Babylon, layoffs at companies like Workit and Calibrate, and Teladoc and Amwell stocks down over 90%. The health of telemedicine in 2024 is complex and seemingly contradictory. Key Highlights: • Telemedicine is thriving within mental health, employing over half of telemedicine clinicians. One could think of telemedicine as split between mental health and everything else. • Other telemedicine verticals are still recovering from hyped expectations and over-funding. Metabolic health and physical therapy have shown consistent growth. • Demand for remote clinical jobs far outstrips supply. This is a golden opportunity for organizations able to create remote clinical jobs. • While the pandemic supercharged telemedicine adoption, telemedicine companies are still a small niche (3-4% of medical clinician jobs). https://lnkd.in/gJ8zgPUv

The State of Telemedicine in 2024

The State of Telemedicine in 2024

singleaimhealth.com

To view or add a comment, sign in

Explore topics